Exelon (EXC) is back on some investors’ radar after recent trading, with the stock last closing at $49.11. That price sits against a mixed pattern of short and longer term total returns.
See our latest analysis for Exelon.
Recent trading has added to Exelon’s 11.82% year to date share price return and 12.66% 90 day share price return. Longer term total shareholder returns of 10.75% over 1 year and 84.27% over 5 years indicate steady compounding.
If you are comparing Exelon with other utilities and infrastructure names, it can be helpful to broaden your watchlist with power grid and energy infrastructure ideas via the 26 power grid technology and infrastructure stocks.
With Exelon posting steady total returns and trading near a US$51.29 analyst target, the key question is whether current earnings and growth are already reflected in the price, or if today’s level still leaves room for upside.
Most Popular Narrative: 3.5% Undervalued
On the most followed narrative, Exelon’s fair value of $50.88 sits a little above the latest $49.11 close, which keeps the focus squarely on what is driving that gap.
The significant identified pipeline ($10B to $15B) in future transmission projects, combined with proven success in competitive bidding, provides clear visibility for outsized capital investment prospects that are expected to increase the regulated asset base and deliver compounding earnings and cash flow growth.
Proactive regulatory engagement and alignment with state policymakers seeking to ensure grid reliability and affordability amid rising demand position Exelon to benefit from constructive rate outcomes and potential utility-owned generation returns, reducing regulatory risk and supporting both earnings visibility and net margin resilience.
Want to see what sits behind that fair value lift? The narrative leans on steady revenue expansion, firmer margins and a future earnings multiple that still trails the sector. Curious which exact assumptions do the heavy lifting.
Result: Fair Value of $50.88 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, that story can break quickly if regulators push back on rate requests or if rising grid investment and financing costs squeeze margins more than expected.
Find out about the key risks to this Exelon narrative.
Another Angle On Value: DCF Pulls The Other Way
While the analyst narrative points to Exelon being about 3.5% undervalued at a fair value of $50.88, the SWS DCF model comes to a very different conclusion. On that view, Exelon at $49.11 sits well above an estimated future cash flow value of $18.37. This screens as overvalued and raises the question of which story you trust more: earnings multiples or long range cash flow math.
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Exelon for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 62 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
This split story of fair value and DCF makes sentiment on Exelon more finely balanced. Act quickly, review the full data and weigh up the 4 key rewards and 2 important warning signs
Looking for more investment ideas?
If Exelon is on your watchlist, do not stop there. Use screeners to surface other opportunities quickly so you are not late to the next move.
- Target consistency by checking out companies that show resilient profiles in the 62 resilient stocks with low risk scores.
- Hunt for potential value by scanning the 62 high quality undervalued stocks that may fit your return and quality preferences.
- Spot income opportunities by reviewing the 12 dividend fortresses that combine higher yields with business fundamentals you can assess in detail.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com